Skip to main content
RemeGen Co., Ltd. logo

RemeGen Co., Ltd. — Investor Relations & Filings

Ticker · 9995 ISIN · CNE1000048G6 LEI · 300300M9HCX4TFAD4I10 HKEX Manufacturing
Open in API
Filings indexed 1,625 across all filing types
Latest filing 2020-11-03 Regulatory Filings
Country CN China
Listing HKEX 9995

About RemeGen Co., Ltd.

http://www.remegen.com

RemeGen Co., Ltd. is a biopharmaceutical company dedicated to the discovery, development, production, and commercialization of innovative biological drugs. The company focuses on creating first-in-class and best-in-class therapeutics to address significant unmet clinical needs, particularly in the critical therapeutic areas of autoimmune diseases, oncology, and ophthalmology. RemeGen utilizes proprietary technology platforms capable of discovering, screening, and developing new molecules and efficiently optimizing production processes. Its pipeline includes a series of innovative biologics, such as Telitacicept, and features 8 clinical pipelines, over 40 clinical trials, and more than 600 patent applications, demonstrating a strong commitment to R&D and innovation in biopharmaceuticals.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movement in Securities for the month ended 31 October 2020
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/10/2020 and submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, including ordinary shares, preference shares, share options, warrants, convertibles, and other share-related instruments. It includes confirmations by the company secretary regarding compliance with listing rules and legal requirements. The content focuses on share capital changes and confirmations related to securities issued during the month. This type of document is a regulatory filing reporting share capital movements and confirmations to the stock exchange, not a full financial report or announcement of voting results. It does not contain financial statements or earnings data, nor is it a proxy or remuneration report. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a compliance report submitted to the exchange regarding share capital movements and confirmations.
2020-11-03 English
GREEN APPLICATION FORM
Share Issue/Capital Change Classification · 95% confidence The document is an application form for a Hong Kong public offering of shares by RemeGen Co., Ltd. It references a prospectus dated October 28, 2020, and details the number of shares offered, pricing, and legal disclaimers related to the offering. The content is focused on the process of applying for shares in the global offering and includes terms and conditions for applicants. This is clearly related to an initial public offering (IPO) or share issuance event. The document is not a report, transcript, or announcement of voting results, nor is it a regulatory filing or management information. It is a capital market document related to the issuance of new shares to the public. Therefore, the most appropriate classification is Share Issue/Capital Change (SHA). The document length and detail confirm it is not a mere announcement but a substantive application form for share issuance.
2020-10-27 English
GLOBAL OFFERING
Capital/Financing Update Classification · 95% confidence The document is a prospectus for a global offering of shares by RemeGen Co., Ltd., detailing the number of shares offered, offer price, underwriting arrangements, and application procedures. It includes information typical of an IPO or share issuance prospectus, such as underwriting details, offer price range, and application instructions. There is no indication of financial statements, management discussion, or audit information. The document is not a report but an offering prospectus related to capital raising. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed offering information, not just an announcement or a brief notice, supporting a high confidence classification.
2020-10-27 English
GLOBAL OFFERING
Capital/Financing Update Classification · 95% confidence The document is an announcement related to a Global Offering of shares by RemeGen Co., Ltd. It includes details about the number of shares offered, pricing, application procedures, underwriting arrangements, and regulatory disclaimers. The text references a prospectus dated October 28, 2020, and discusses the offering structure, over-allotment options, and listing application. There is no financial performance data, earnings information, or management discussion. The document is clearly an announcement about a capital raising event and share issuance rather than a full financial report or regulatory certification. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2020-10-27 English
RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 21 OCTOBER 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the results of an Extraordinary General Meeting (EGM) held on 21 October 2020. It details the voting outcome on a specific resolution related to equity and debt transfer agreements. The text references the EGM Notice and Circular but does not contain full financial statements or detailed financial analysis. The document is relatively short (4763 characters) and serves to inform shareholders and the public of the voting results rather than presenting a full report or detailed financial data. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2020-10-21 English
PHIP (1st submission)
Regulatory Filings Classification · 95% confidence The document is a 'PHIP' (Post-Hearing Information Proof), which is a preliminary prospectus filed by a company (RemeGen Co., Ltd.) in the context of an upcoming IPO on the Hong Kong Stock Exchange. The document structure lists various sections typical of a prospectus, such as 'Risk Factors', 'Industry Overview', 'Business', and 'Accountants' Report'. Since the provided categories do not include a specific 'IPO Prospectus' code, and it is a regulatory filing related to a capital market event, it falls under the 'Regulatory Filings' (RNS) category as the most appropriate fallback.
2020-10-21 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.